Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. Morice MC, et al. N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843. N Engl J Med. 2002. PMID: 12050336 Free article. Clinical Trial.
Triple vessel stenting for triple vessel coronary disease.
Villegas B, Morice MC, Hernandez S, Choussat R, Dumas P, Lefevre T, Louvard Y, Loubeyre C, Fajadet J, Marco J. Villegas B, et al. Among authors: morice mc. J Invasive Cardiol. 2002 Jan;14(1):1-5. J Invasive Cardiol. 2002. PMID: 11773686 Clinical Trial.
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC; RAVEL Study Group. Serruys PW, et al. Among authors: morice mc. Circulation. 2002 Aug 13;106(7):798-803. doi: 10.1161/01.cir.0000025585.63486.59. Circulation. 2002. PMID: 12176950 Free article. Clinical Trial.
Clinical and angiographic results with the NIR stent: First International NIR Endovascular Stent Study (FINESS-II).
Rutsch W, Kiemeneij F, Colombo A, Macaya C, Guermonprez JL, Grip L, Hamburger J, Umans V, Gotsman M, Almagor Y, Morice MC, Garcia E, Chevalier B, Erbel R, Cobaugh M, Morel MA, Serruys PW. Rutsch W, et al. Among authors: morice mc. Int J Cardiovasc Intervent. 2000 Sep;3(3):143-151. doi: 10.1080/14628840050516055. Int J Cardiovasc Intervent. 2000. PMID: 12470364
Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial.
Abizaid A, Costa MA, Blanchard D, Albertal M, Eltchaninoff H, Guagliumi G, Geert-Jan L, Abizaid AS, Sousa AG, Wuelfert E, Wietze L, Sousa JE, Serruys PW, Morice MC; Ravel Investigators. Abizaid A, et al. Among authors: morice mc. Eur Heart J. 2004 Jan;25(2):107-12. doi: 10.1016/j.ehj.2003.11.002. Eur Heart J. 2004. PMID: 14720526 Clinical Trial.
506 results